Cargando...
Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis
AIMS: In Spain, the first line treatment of hyperphosphatemia in Chronic Kidney Disease (CKD) consists of calcium-based phosphate binders (CB). However, their use is associated with vascular calcification and an increased mortality risk. The aim of this study was to assess the incremental cost-effec...
Guardado en:
Publicado en: | Health Econ Rev |
---|---|
Autores principales: | , , , , , , , |
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4467815/ https://ncbi.nlm.nih.gov/pubmed/26062537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13561-015-0049-3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|